|
Report ID
|
178385 |
|
Drug Identification Number
|
02162849 |
|
Brand name
|
GLUCOPHAGE |
|
Common or Proper name
|
GLUCOPHAGE 850 mg |
|
Company Name
|
SANOFI-AVENTIS CANADA INC |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
METFORMIN HYDROCHLORIDE |
|
Strength(s)
|
850MG |
|
Dosage form(s)
|
TABLET |
|
Route of administration
|
ORAL
ORAL |
|
Packaging size
|
100 |
|
ATC code
|
A10BA |
|
ATC description
|
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
|
Reason for shortage
|
Other (Please describe in comments) |
|
Anticipated start date
|
|
|
Actual start date
|
2022-12-13 |
|
Estimated end date
|
2023-08-31 |
|
Actual end date
|
2023-08-31 |
|
Shortage status
|
Resolved |
|
Updated date
|
2023-09-01 |
|
Company comments
|
Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
email: [email protected]
Telephone: 1-800-265-7927 |
